Patent Assignment
Reel/Frame 064576/0383
Corrective Assignment to Correct the the Assignment Document Previously Recorded at Reel: 057325 Frame: 0672. Assignor(S) Hereby Confirms the Assignment.
Recorded: 2023-08-14
Pages: 7
Assignor
HUSSAIN, ABID
Executed: 2021-08-17
Assignee
ANOVENT PHARMACEUTICAL (U.S.), LLC
ONE GATEWAY CENTER, SUITE 2600, NEWARK, NEW JERSEY, 07102
Covered Properties
(3)
Liposome Formulation of Fluticasone Furoate and Method of Preparation
Pharmaceutical Formulation Containing Remdesivir and Its Active Metabolites for Dry Powder Inhalation
Application:
17/323,109 →
Publication:
US 2021/0353650
Pharmaceutical Formulation Containing Combination of M3 Antagonist-Beta-2 Agonist and Inhaled Corticosteroids
Application:
17/361,471 →
Publication:
US 2021/0401855
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 30, 2021
From: HUSSAIN, ABID
To: ANOVENT PHARMACEUTICAL (U.S.), LLC
Reel/Frame 057325/0672 →
Assignment of Assignor's Interest
Aug 30, 2021
From: ZHANG, HAI LONG
To: ANOVENT PHARMACEUTICAL (U.S.), LLC
Reel/Frame 057325/0917 →
Assignment of Assignor's Interest
Aug 30, 2021
From: HUANG, CAI GU
To: ANOVENT PHARMACEUTICAL (U.S.), LLC
Reel/Frame 057326/0322 →
Change of Name
Jun 13, 2023
From: ANOVENT PHARMACEUTICAL (U.S.), LLC
To: ANOBRI PHARMACEUTICALS US, LLC
Reel/Frame 063983/0307 →
Corrective Assignment to Correct the Assignment Document Previously Recorded at Reel: 057325 Frame: 0917. Assignor(S) Hereby Confirms the Assignment.
Aug 14, 2023
From: ZHANG, HAI LONG
To: ANOVENT PHARMACEUTICAL (U.S.), LLC
Reel/Frame 064576/0257 →
Corrective Assignment to Correct the Assignment Document Previously Recorded at Reel: 057326 Frame: 0322. Assignor(S) Hereby Confirms the Assignment.
Aug 14, 2023
From: HUANG, CAI GU
To: ANOVENT PHARMACEUTICAL (U.S.), LLC
Reel/Frame 064576/0500 →